Literature DB >> 17563060

Screening for insulitis in adult autoantibody-positive organ donors.

Peter In't Veld1, Dirk Lievens, Joeri De Grijse, Zhidong Ling, Bart Van der Auwera, Miriam Pipeleers-Marichal, Frans Gorus, Daniel Pipeleers.   

Abstract

Antibodies against islet cell antigens are used as predictive markers of type 1 diabetes, but it is unknown whether they reflect an ongoing autoimmune process in islet tissue. We investigated whether organs from adult donors that are positive for autoantibodies (aAbs) against islet cell antigens exhibit insulitis and/or a reduced beta-cell mass. Serum from 1,507 organ donors (age 25-60 years) was analyzed for islet cell antibodies (ICAs), glutamate decarboxylase aAbs (GADAs), insulinoma-associated protein 2 aAbs (IA-2As), and insulin aAbs. Tissue from the 62 aAb+ donors (4.1%) and from matched controls was examined for the presence of insulitis and for the relative area of insulin+ cells. Insulitis was detected in two cases; it was found in 3 and 9% of the islets and consisted of CD3+/CD8+ T-cells and CD68+ macrophages; in one case, it was associated with insulin+ cells that expressed the proliferation marker Ki67. Both subjects belonged to the subgroup of three donors with positivity for ICA, GADA, and IA-2-Ab and for the susceptible HLA-DQ genotype. Comparison of relative beta-cell area in aAb+ and aAb- donors did not show a significant difference. Insulitis was found in two of the three cases that presented at least three aAbs but in none of the other 59 antibody+ subjects or 62 matched controls. It was only detected in <10% of the islets, some of which presented signs of beta-cell proliferation. No decrease in beta-cell mass was detected in cases with insulitis or in the group of antibody+ subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563060     DOI: 10.2337/db07-0416

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  100 in total

1.  Collection protocol for human pancreas.

Authors:  Martha L Campbell-Thompson; Emily L Montgomery; Robin M Foss; Kerwin M Kolheffer; Gerald Phipps; Lynda Schneider; Mark A Atkinson
Journal:  J Vis Exp       Date:  2012-05-23       Impact factor: 1.355

2.  Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes.

Authors:  A Willcox; S J Richardson; A J Bone; A K Foulis; N G Morgan
Journal:  Diabetologia       Date:  2010-06-09       Impact factor: 10.122

3.  Intravital imaging of CTLs killing islet cells in diabetic mice.

Authors:  Ken Coppieters; Natalie Amirian; Matthias von Herrath
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

4.  Beta cells under attack: toward a better understanding of type 1 diabetes immunopathology.

Authors:  Ken T Coppieters; Bart O Roep; Matthias G von Herrath
Journal:  Semin Immunopathol       Date:  2010-12-18       Impact factor: 9.623

5.  Characterization of human organ donors testing positive for type 1 diabetes-associated autoantibodies.

Authors:  A Wiberg; A Granstam; S Ingvast; T Härkönen; M Knip; O Korsgren; O Skog
Journal:  Clin Exp Immunol       Date:  2015-10-06       Impact factor: 4.330

6.  Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans.

Authors:  J J Meier; T G K Breuer; R C Bonadonna; A Tannapfel; W Uhl; W E Schmidt; H Schrader; B A Menge
Journal:  Diabetologia       Date:  2012-05       Impact factor: 10.122

Review 7.  Viruses and cytotoxic T lymphocytes in type 1 diabetes.

Authors:  Ken T Coppieters; Matthias G von Herrath
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 8.  Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".

Authors:  Sally C Kent; Stuart I Mannering; Aaron W Michels; Jenny Aurielle B Babon
Journal:  Curr Diab Rep       Date:  2017-09-02       Impact factor: 4.810

Review 9.  Pancreatic pathology in type 1 diabetes mellitus.

Authors:  Sarah J Richardson; Noel G Morgan; Alan K Foulis
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 10.  Novel diagnostic and therapeutic approaches for autoimmune diabetes--a prime time to treat insulitis as a disease.

Authors:  Juha Grönholm; Michael J Lenardo
Journal:  Clin Immunol       Date:  2014-12-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.